The August 2022 'News from ECOG-ACRIN' blog is now available
In this issue:
- Letter from the Co-Chairs
- NCI-MATCH precision medicine trial leads to FDA drug approval of dabrafenib/trametinib for BRAF V600E-mutated tumors
- Trial Spotlight: Neha Vapiwala on the EA8191/INDICATE Study for Prostate Cancer
- Institution Spotlight: Penn State Cancer Institute
- News in Brief